Daily Company Scan — 5 Companies
🇪🇪 HEVI Optronics
Defense/Optics · Estonia · €20M
Electro-optical systems manufacturer.
Deal angle: Plans €20M investment in second facility; growth equity candidate.
Thesis: HEVI offers scarce Baltic NATO-aligned electro-optics exposure as Estonia ramps defense spending. A €20M growth investor funds capacity doubling into contracts that justify multiples above the 5-9x EV/EBITDA of local peers like Tallink or Apranga. Execution risk on the new facility and thin sector comps may limit exit valuation.
🇪🇪 SilmetDEEP DIVE
Materials · Estonia
Rare-earth processing company.
Deal angle: Selected as EU strategic project; potential for large strategic investment or acquisition.
Thesis: Silmet’s EU strategic project status creates a rare window for a Western acquirer to secure non-Chinese rare-earth processing capacity inside the EU. An investor gains offtake control and potential policy-backed financing at a time when Baltic materials peers trade at 5–9x EV/EBITDA. Execution risk on scaling remains high given the sector’s capex intensity and lack of relevant local comps.
🇪🇪 Golbriak Space
Space Tech · Estonia · €4M
Space technology solutions.
Deal angle: Raised seed funding; potential M&A target in space sector.
Thesis: Golbriak Space's €4M seed round offers a low-entry M&A foothold in Estonia's space tech push, where EU orbital/defense budgets are rising. A strategic buyer gains proprietary tech and local engineering talent far below Baltic peers' 7.7-17x EV/EBITDA multiples. Main risk: early-stage losses likely warrant a steep discount to the 5-10x cluster given zero reported EBITDA.
Ejendomsselskabet Bredstrupvej ApS
· Denmark
Private Danish company (gross-profit basis)
Deal angle: Erhvervsstyrelsen annual reports (CVR)
Thesis: Ejendomsselskabet Bredstrupvej offers a Danish gross-profit property vehicle for Baltic or Nordic buyers seeking low-correlation real estate exposure while peers trade at 5.1-17.0x EV/EBITDA. An acquirer gains immediate Denmark footprint and potential re-rating upside versus Tallinna Sadam’s 42.6% margin or TKM’s 4.2%. Key risk: minimal segment disclosure in CVR filings limits due diligence.
Skrivers byg og montage ApS
· Denmark
Private Danish company (gross-profit basis)
Deal angle: Erhvervsstyrelsen annual reports (CVR)
Thesis: Skrivers byg og montage ApS provides a Danish construction platform for Baltic operators (Grigeo, Tallinna Sadam, Apranga) trading at 5.6-9.1x EV/EBITDA to add cross-border revenue at similar or lower multiples. An acquirer secures gross-profit-based earnings and EU execution capacity with minimal listed-premium cost. Opaque CVR filings and zero sector disclosure raise execution and valuation risks.
Deep Dive
🇪🇪 Silmet
Materials · Estonia · Selected as EU strategic project; potential for large strategic investment or acquisition.
Company Overview
Silmet is an Estonian rare-earth processing firm operating in the materials sector. The company focuses on separating and refining rare-earth elements, a niche critical for magnets, electronics, and defense applications. With revenue below €10 million, it remains a small-scale operator relative to global peers, likely concentrated on pilot or early commercial volumes rather than large integrated facilities.
Deal Context
EU strategic project designation creates a clear M&A catalyst. The status unlocks potential policy support and positions Silmet as a target for Western strategic buyers seeking secure, non-Chinese processing capacity inside the EU single market. Likely acquirers include European specialty chemicals groups, defense contractors, or state-backed entities prioritizing supply-chain resilience. The opportunity leans toward a strategic acquisition or growth equity round rather than classic PE succession.
Valuation Context
Listed Baltic peers trade at a wide 5–9x EV/EBITDA range for more mature industrial and consumer names, with outliers above 17x. As a private company with sub-€10 million revenue and limited track record, Silmet would face a 40–60% private-company discount to those multiples. Realistic entry valuation would likely be framed on a revenue basis of 2–4x, reflecting high capex needs and execution risk rather than current EBITDA.
Triage Verdict
GO
- Fit: Strong sector tailwinds, EU policy backing, and Baltic location align with strategic supply-chain mandates.
- Red flags: Small scale, high capex intensity, and absence of relevant local listed comps increase execution uncertainty.
- Next step: Request detailed capex plan, offtake agreements, and technology validation data before engaging the founder.
Key Risk
Delays or cost overruns in scaling from pilot to commercial volumes could erode the policy advantage and deter strategic investors.
Bottom line: EU designation gives Silmet a credible path to a strategic exit at a premium to Baltic private-market norms.
IPO Pipeline Snapshot
Upcoming IPOs
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Pelican Acquisition II Corp | PLCIU | UNKNOWN | TBD | $86.2M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| GLGHK Ltd | GLG | UNKNOWN | TBD | $40.2M |
Pre-IPO Watchlist
| Company | Sector | Valuation |
|---|---|---|
| OpenAI | Artificial Intelligence | $1.2T |
| Anthropic | Artificial Intelligence | $965.0B |
| Databricks | Data and Analytics | $201.6B |
Deal Radar — Buyer ↔ Target Synergy Pairs
🇳🇴 Norway · 3 pairs
BUYER · PUBLIC
EQUINOR
EQNR.OL · $1024.6B
→
4.00
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€3340.5M rev
Solid — pursue with focused integration plan.
Largest lever is cost/operational consolidation of overlapping Norwegian upstream operations; primary risk is regulatory scrutiny of further NCS concentration and execution of platform/facility rationalisation.
BUYER · PUBLIC
AF GRUPPEN
AFG.OL · $21.4B
→
3.65
TARGET · PRIVATE
ABB HOLDING AS
Installasjon av industrimaskiner og -utstyr · ~€875.9M rev
Solid — pursue with focused integration plan.
AF Gruppen gains immediate scale in industrial installation via a large domestic target, with the primary lever being cost synergies from operational overlap. Realisation risk is mainly revenue-related and integration effort on a target representing ~25-30% of buyer revenue.
BUYER · PUBLIC
TotalEnergies SE
TTE · $201.4B
→
3.55
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€3340.5M rev
Solid — pursue with focused integration plan.
Largest lever is cost_operational scale in upstream gas (procurement and facilities). Main risk is modest revenue upside plus Norwegian regulatory scrutiny on foreign ownership of strategic energy assets.
🇪🇪 Estonia · 3 pairs
BUYER · PUBLIC
E.ON SE N
EOAN.DE · $46.7B
→
3.60
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
Primary synergy is cost/operational scale in energy procurement and overheads; strategic Baltic expansion is secondary. Biggest risk is geographic and cultural integration friction that could delay or reduce capture.
BUYER · PUBLIC
Fortum Corporation
FORTUM.HE · $21.1B
→
3.55
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
Largest lever is cost_operational consolidation of generation and procurement (35% weight, score 4); primary risk is slower organisational alignment due to cross-border state ownership. Overall score supports a focused Baltic roll-up with realistic 70% cost-synergy capture over 24 months.
BUYER · PUBLIC
PKN C.XWAR PLN
PKN.WA · $179.9B
→
3.55
TARGET · PRIVATE
ORLEN EESTI OÜ
Wholesale And Retail Trade; Repair Of Motor Vehicles And Motorcycles · ~€1158.7M rev
Solid — pursue with focused integration plan.
PKN Orlen gains reliable Baltic retail access and supply-chain efficiencies from its refineries; largest lever is cost/operational integration while key risk is modest revenue upside in a small market with standard post-deal execution hurdles.
🇩🇰 Denmark · 3 pairs
BUYER · PUBLIC
SIEGFRIED N
SFZN.SW · $3.1B
→
3.55
TARGET · PRIVATE
FUJIFILM Diosynth Biotechnologies Denmark ApS
· ~€790.7M rev
Solid — pursue with focused integration plan.
The core lever is strategic capability expansion into biologics CDMO, delivering material long-term positioning upside; cost synergies are only moderate due to technology mismatch while organisational and revenue realisation risks (culture, client overlap execution) warrant conservative haircuts and phased integration.
BUYER · PUBLIC
E.ON SE N
EOAN.DE · $46.7B
→
3.45
TARGET · PRIVATE
Energinet
· ~€720.4M rev
Marginal — deep scrutiny or lower premium.
Primary lever is cost/operational scale in utilities, tempered by limited revenue synergies and cross-border friction; realization haircut of ~30% on cost items due to regulatory and distance factors.
BUYER · PUBLIC
LONZA N
LONN.SW · $42.2B
→
3.10
TARGET · PRIVATE
FUJIFILM Diosynth Biotechnologies Denmark ApS
· ~€790.7M rev
Marginal — deep scrutiny or lower premium.
Lonza gains meaningful biologics manufacturing capacity in Denmark, the primary synergy lever, but direct competitor overlap caps revenue upside and raises integration complexity. Organizational and realization risks dominate, warranting conservative valuation.
Featured Agent
IPO Readiness Assessor
capital · Financial, governance, operational readiness for a listing.
Assesses IPO readiness across four pillars: financial (reporting, audits, internal controls), governance (board, policies), operational (systems, scalability), and market (timing, comparables, investor demand).
Its editable system prompt:
# IPO Readiness Assessor You assess a company's readiness to go public across four pillars. ## Four pillars (each scored 0-10) ### 1. Financial readiness - Audit status (Big-4 / second-tier, # of clean audits) - Accounting framework (IFRS / US GAAP) - Internal controls & SOX (or equivalent) readiness - Revenue recognition policies, consistency - Financial planning & KPIs ### 2. Governance readiness - Board composition & independence - Audit committee (independent chair, financial expert) - Compensation committee & equity plans - Disclosure controls, risk management framework ### 3. Operat…